rush university

(Rush University Medical Center) Neurological experts from across the U.S. and other countries including a nationally renowned researcher from Rush University Medical Center will discuss the latest findings in basic and clinical research for Fragile X at the 11th International Fragile X Conference, to be held July 23-27 in St.

Louis. Families with children who are diagnosed with Fragile X also will be attending the conference.

(Rush University Medical Center) Difficulty falling asleep and staying asleep increase as women go through menopause according to research by Rush University Medical Center.

Waking up earlier than planned also increases through late perimenopause but decreases when women become postmenopausal.

The study is published in the July 1 issue of the journal SLEEP.

(Rush University Medical Center) A CD26 Inhibitor increases the efficiency and responsiveness of umbilical cord blood for bone marrow transplants and may improve care for blood cancer patients according to research from Rush University Medical Center being presented at the 6th Annual International Umbilical Cord Blood Transplantation Symposium, June 6-7 in Los Angeles.

(Rush University Medical Center) A novel cell therapy using retinal pigment epithelial cells attached to tiny gelatin bead microcarriers implanted in the brain can improve the symptoms of patients with moderate to advanced Parkinson's disease.

Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study by researchers at Rush University Medical Center.

The study is published in the March issue of the journal Gender Medicine.